Menu

Blog

Archive for the ‘biotech/medical’ category: Page 2076

May 28, 2019

What’s Telling About Telomeres (and the Aging Process)

Posted by in categories: biotech/medical, life extension

Is aging a natural process that we simply have to accept as a fact of life?

A philosopher would say yes. Many doctors would also agree: that our cells eventually reach a point where they can no longer divide and either die or reach senescence, a retirement phase. Many scientists believe in the “Hayflick limit” — that no one can live past about 120 years old. These people might also say that aging — and dying — is a good thing; that the world is already overcrowded, that we already cannot handle our aging populations, that life must be finite to appreciate it, that all good things must come to an end.

But there’s a growing group of people — including gerontologists, biologists, engineers, and futurists—who believe that aging is a disease in itself, a disease that can be cured. That aging is not an immutable process, an inevitable “dying of the light,” to quote poet Dylan Thomas, but one we can “rage against” — through science, drugs, and lifestyle changes.

Continue reading “What’s Telling About Telomeres (and the Aging Process)” »

May 28, 2019

Building the Future of Global Health: Big Tech’s Big Ideas

Posted by in categories: biotech/medical, business, life extension

Ira Pastor, ideaXme longevity and aging ambassador and founder of Bioquark interviews Luba Greenwood J.D., Strategic Business Development and Corporate Ventures, Verily (Google Life Sciences), Board Member Mass Bio and Brooklyn ImmunoTherapeutics LLC.

Note: Following this interview, Verily announced a major set of collaborations with big pharma companies, further executing on its strategy in healthcare. Breaking news: https://www.cnbc.com/2019/05/20/alphabet-verily-doing-clinic…T4eLzIucEI

Continue reading “Building the Future of Global Health: Big Tech’s Big Ideas” »

May 28, 2019

Brain Implants Market: World Approaching Demand & Growth Prospect by 2024

Posted by in categories: biotech/medical, neuroscience

Brain implants are the neural implants that directly connected to the brain. These implants electrically stimulate, block or record the signals from the brain. It enables communication between the brain and electronic devices, thus permitting brain activity to be modified, recorded or translated. This growth is primarily driven by Increased Neurological Disorders Like Alzheimer’s disease and Rise in Geriatric Population.

Advance Market Analytics recently introduced Brain Implants Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2025. Brain Implants Market explores effective study on varied sections of Industry like opportunities, size, growth, technology, demand and trend of high leading players. It also provides market key statistics on the status of manufacturers, a valuable source of guidance, direction for companies and individuals interested in the industry.

Read more

May 28, 2019

Developing a Biotechnology Startup in the Rejuvenation Field

Posted by in categories: biotech/medical, life extension

Alongside our Ending Age-related Diseases 2019 annual conference, we are proud to announce the launch of a special pre-conference biotech workshop led by Dr. Kelsey Moody, CEO of Ichor Therapeutics, a successful and rapidly growing rejuvenation biotechnology company.

This joint event between the Life Extension Advocacy Foundation and Ichor Therapeutics is an essential workshop where you will learn about the fundamentals of launching and growing a successful biotechnology company with an emphasis on the nuances specific to the emerging rejuvenation biotechnology industry.

Read more

May 28, 2019

Medical Benefits of Snake Venom

Posted by in category: biotech/medical

Snake venom has some amazing medical applications!

Read more

May 28, 2019

New Pacemaker Harvests Energy from the Heart

Posted by in category: biotech/medical

A device that converts the heart’s mechanical energy into electrical energy has been successfully tested in pigs.

  • By Harini Barath on May 28, 2019

Read more

May 28, 2019

Provocative study shows how the herpes virus can speed up the onset of Alzheimer’s disease

Posted by in categories: biotech/medical, neuroscience

An intriguing new study from researchers at Stockholm University and Karolinska Institutet has described a mechanism by which virus particles can interact with proteins in biological fluids and become more infectious, while also accelerating the formation of plaques often associated with neurodegenerative diseases such as Alzheimer’s.

Read more

May 28, 2019

Transhumanism Is Tempting—Until You Remember Inspector Gadget

Posted by in categories: biotech/medical, computing, food, transhumanism

It’s comforting to think of the body as a machine we can trick out. It helps us ignore the strange fleshy aches that come with having a meat cage. It makes a fickle system—one we truly don’t understand—feel conquerable. To admit that the body (and mind that sits within it) might be far more complex than our most delicate, intricate inventions endangers all kinds of things: the medical industrial complex, the wellness industry, countless startups. But it might also open up new doors for better relationships with our bodies too: Disability scholars have long argued that the way we see bodies as “fixable” ultimately serves to further marginalize people who will never have the “standard operating system,” no matter how many times their parts are replaced or tinkered with.


Tech gurus are obsessed with treating bodies like machines—something a 30-year-old cartoon about a tricked-out detective suggests won’t work.

Read more

May 27, 2019

Autism linked to ‘junk’ DNA mutations

Posted by in categories: biotech/medical, neuroscience

Mutations in so-called “junk” DNA have been tied to the development of autism (ASD) in children who do not have parents or siblings with the condition.


For the first time, research links non-coding DNA to disorder development. Andrew Masterson reports.

Read more

May 27, 2019

Signs of selection in the stomach

Posted by in categories: biotech/medical, evolution, genetics

Helicobacter pylori, a globally distributed gastric bacterium, is genetically highly adaptable. Microbiologists at LMU have now characterized its population structure in individual patients, demonstrating an important role of antibiotics for its within-patient evolution.

The cosmopolitan bacterium Helicobacter pylori is responsible for one of the most prevalent chronic infections found in humans. Although the infection often provokes no definable symptoms, it can result in a range of gastrointestinal tract pathologies, ranging from inflammation of the lining of the stomach to gastric and duodenal tumors. Approximately 1 percent of all those infected eventually develop stomach cancer, and the World Health Organization has classified H. pylori as a carcinogen. One of Helicobacter pylori’s most striking traits is its genetic diversity and adaptability. Researchers led by microbiologist Sebastian Suerbaum (Chair of Medical Microbiology and Hospital Epidemiology at LMU’s Max von Pettenkofer Institute have now examined the genetic diversity of the species in the stomachs of 16 patients, and identified specific adaptations that enable the bacterium to colonize particular regions of the stomach.

Read more